Alaunos Therapeutics, Inc. Logo

Alaunos Therapeutics, Inc.

Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.

TCRT | US

Overview

Corporate Details

ISIN(s):
US98973P1012
LEI:
Country:
United States of America
Address:
501 E LAS OLAS BLVD, 33301 FORT LAUDERDALE

Description

Alaunos Therapeutics, Inc. is a clinical-stage cellular immuno-oncology company developing T-cell receptor (TCR)-T cell therapies for the treatment of solid tumors. The company's approach targets cancer-specific neoantigens that arise from genomic hotspot mutations. It utilizes its proprietary hunTR® (human neoantigen T cell Receptor) platform as a discovery engine to identify and expand its library of tumor-specific TCRs. For manufacturing its cell therapies, Alaunos employs the *Sleeping Beauty* non-viral gene transfer system, a technology noted for its favorable safety profile and rapid, cost-effective production. The company's mission is to deliver tumor-specific T-cell therapies to cancer patient populations with unmet clinical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-23 18:18
8-K
English ZIP 65.3 KB
2025-12-11 23:17
424B8
English ZIP 153.5 KB
2025-12-05 21:20 English ZIP 417.8 KB
2025-11-27 03:32
4
English ZIP 7.2 KB
2025-11-27 03:26
4
English ZIP 7.1 KB
2025-11-27 03:26
4
English ZIP 6.7 KB
2025-11-14 22:15
10-Q
English ZIP 1.0 MB
2025-11-07 22:34
S-3/A
English ZIP 206.1 KB
2025-10-31 19:13 English ZIP 4.0 MB
2025-10-30 23:48 English ZIP 3.1 MB
2025-10-22 01:25
S-1
English ZIP 237.8 KB
2025-10-16 22:58 English ZIP 8.1 KB
2025-10-02 02:10
S-3/A
English ZIP 196.2 KB
2025-09-09 02:11
S-3/A
English ZIP 306.9 KB
2025-09-05 23:20 English ZIP 10.4 KB

Automate Your Workflow. Get a real-time feed of all Alaunos Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alaunos Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alaunos Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
Compugen Ltd. Logo
A clinical-stage company developing cancer immunotherapies using an AI platform.
Israel
CGEN
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480
CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.